Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liao, Qinping
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer	Recruiting	2	196	RoW	TQB2450, Anlotinib	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Advanced Endometrial Cancer	12/21	04/22
NCT05383521: Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis	Not yet recruiting	N/A	20	RoW	Tinidazole 56, Tinidazole M56, Tinidazole 42, Tinidazole M42	Shangrong Fan	Trichomonas Vaginitis	12/25	12/25